Chemistry Sizzles At Tipping Point Show

Sandra Birch, Julia Glander and Connie Cowper in The Cemetery Club at Tipping Point Theatre. Photo: Ivan Menchell

By Jenn McKee, EncoreMichigan.com

To sell a play about friendship, the actors ultimately have to if youll forgive the cliche have the right chemistry. Their energy has to build on each other so that not only do we believe in their deep and abiding bond, but we also enjoy our time with them, as though we are a virtual, silent, additional friend.

Tipping Point Theatres production of Ivan Menchells The Cemetery Club features a leading ensemble that has that chemistry down; what they lack is a script that feels like more than an occasionally funny, warmed-over sitcom.

Set in the Queens apartment of a Jewish widow named Ida (Julia Glander), Cemetery tells the story of a three-way friendship at a crossroads. Doris (Connie Cowper) is a devoted widow with no interest in finding new love; Lucille (Sandra Birch) is a loud, bargain-loving, man-hungry widow who wants to stop looking back to the past; and Ida is ready, after losing her husband two years before, to venture back into dating.

When Ida runs into Sam (Thomas D. Mahard), a local butcher, they pursue a relationship, but the way is anything but smooth.

Beth Torrey directs the show with an eye toward really anchoring it in the womens friendship and the complications that arise when that triumvirate is threatened. An extended scene when the women are drunk, after coming home from a wedding, is a highlight.

And spending time with these women is often fun, thanks to the actresses unbridled performances. But the play itself feels bloated at two hours; the plays stakes just dont feel that high. And too much along the way rings predictable and familiar: The women rib each other about lying about their age, and how, if you dont like being alone, get a dog, not a man; Lucille repeatedly makes the others guess how much she paid for various clothing items; and sometimes, the schmaltz runs painfully thick (one secret is screamed mid-argument, followed by violent weeping, for instance).

Lucille, being the extroverted vixen of the trio, gets the lions share of funny lines and moments, and Birch cashes them in with deliciously playful zest. Cowper, meanwhile, effectively straddles the line between a sanctimonious goody-two-shoes and a well-intentioned, good-hearted angel on Idas shoulder. Brenda Lane brings a much-appreciated bolt of new energy to the production when her character makes a surprise arrival (I wont say more at the risk of ruining the surprise); and Mahards Sam is a man we want to like, but come to doubt.

Ultimately, though, the show hinges on Ida and her personal journey, and Glanders performance is a knockout. From tentatively tiptoeing toward courtship, to drunkenly commiserating with girlfriends and then being struck speechless in the face of tragedy Glander makes you root, and ache, for Ida.

Read the original:
Chemistry Sizzles At Tipping Point Show

Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting

LOS ANGELES--(BUSINESS WIRE)--

Puma Biotechnology, Inc. (OTCBB: PBYI.OB - News), a development stage biopharmaceutical company, announced that clinical data for its lead drug candidate PB272 (neratinib) in patients with metastatic breast cancer will be presented in the HER2/ER Breast Cancer poster session at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting. The ASCO Annual Meeting will be held June 1 5, 2012, in Chicago.

Details of the poster presentation are as follows:

Abstract #611: A phase I dose-escalating study evaluating weekly paclitaxel with neratinib and trastuzumab in women with metastatic HER-2 positive breast cancer, NSABP FB-8. Rachel C. Jankowitz, MD Poster Board #10F, S Hall A2, Saturday, June 2, 8:00 a.m. 12 Noon

About Puma Biotechnology

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.

Further information about Puma Biotechnology can be found at http://www.pumabiotechnology.com.

Forward-Looking Statements:

This press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors, which include, but are not limited to, the risk factors disclosed in the periodic reports filed by the Company with the Securities and Exchange Commission from time to time. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update these forward-looking statements, except as required by law.

Link:
Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting

'Grey’s Anatomy': Please Stop Banking On Your Finales

Ever since Grey's Anatomy premiered on March 27, 2005, I've been hooked. Whether I was educating myself with medical jargon (did I mention I have a Ph.D. in surgical lingo?) or swooning over the McDreamy-Meredith romance, I was officially diagnosed with Grey's Obsession. It was a beautiful (albeit semi-unhealthy) relationship that I was happy to be a part of. But somewhere along the way, Grey's has lost a bit of its edge. It's developed a pattern of repetition, downgrading the caliber of its episodes. However, I continue to get roped back in year after year after year for one major reason: The epic Grey's Anatomy finales.

Yes, creator Shonda Rimes definitely knows how to leave an audience hanging with her numerous finale cliffhangers. And as the years have progressed, the finales have become bigger and bigger even reaching new heights (literally) with last week's devastating plane crash. (Did we mention this looks a little familiar?)It really is great television at its finest. Rimes knows it, we know it. But therein lies the problem. Rimes has become so comfortable with piquing our interests come finale time, that she's neglecting to give viewers exciting content throughout the rest of the season. It's like she's saving up all of her good material for the final episode, but we need more than that.

Now, please remember that I've already demonstrated my profound allegiance to the show, so my disappointment does not come lightly. But I'm growing tired of the repetitive storylines that seem to go absolutely nowhere from week to week. For weeks I've wanted something monumental to happen and now that it has, I'm annoyed at how long I had to wait to get there.

This isn't just a one-time thing, though. It's something the show has been getting away with for years. Whether it be a tragic death from a beloved character (R.I.P., George) or a devastating hospital shooting, the series has solely banked on these finales to get fans to come back for the following season even when the rest of the episodes make us want to throw in the towel. It's the perfect trap. And it may have worked again this time, my patience is wearing thin.

These finales prove Grey's still has the potential to be the show we once knew, but it needs to start showing more of that throughout the entire season, not just at the end. A plane crash is suspenseful, but I'd much rather settle for a less shocking finale (like when Meredith discovered McDreamy was married in Season 1) if it meant raising the bar on the caliber of content as a whole. Fans don't want all the intrigue to be crammed into one episode and then be done with it we want a little foreplay along the way.

So please, Grey's Anatomy, you know I love you, but stop relying solely on your finales to be the main course of the show. Because one of these days, I may not stick around for seconds. Now, scrub up and get to work!

Grey's Anatomy kicks off their finale tonight, May 17 at 9 PM (ET/PT) on ABC. Will you be watching?

More: Grey's Anatomy Characters Get LOST VIDEO Which Greys Anatomy Doctors Will Return Next Fall? Greys Anatomy Finale Details Emerge, Get Em While Theyre McSteamy

Continue reading here:
'Grey’s Anatomy': Please Stop Banking On Your Finales

‘Grey’s Anatomy’ season finale: Who will die?

Image Credit: Vivian Zink/ABC

Shonda Rhimes is fierce. But not in the Tyra Oh, you look so fierce Banks way. I mean fierce as in Im not afraid to kill off one of my beloved characters all in the name of good television kind of way.

In the weeks before tonights season finale, the executive producer and creator behind the show has made no secret of the fact that we should brace ourselves to say goodbye to a cast member before the season ends. Note how I said cast member and not doctor.

Last weeks episode ran relatively calm as the residents made their decisions to leave Seattle Grace or stay put until the last two minutes, when a plane carrying a handful of doctors crashed somewhere in the Northwestern wilderness. So who is leaving us tonight? We know Patrick Dempsey, Sandra Oh, Ellen Pompeo, and Justin Chambers are signed on for two moreseasons, so Im counting them out. But here are my thoughts on which character might be signing off:

Adele: Played by the outstanding Loretta Devine, Adele has been suffering from a severe case of Alzheimers this season, which is why its important to note that a cast member is leaving. Adeles condition has been consistently deteriorating, so much so that shes fallen in love with another Alzheimers patient and has started sleeping with him. My heart broke when Richard walked in on them, and I wouldnt be shattered if she was the one to leave. Outside the comfort of Dr. Catherine Avery, Richard needs some peace of mind.

Callie/Arizona: The loving couple had a minimal amount of hardship this year until Arizona had to deal with a failed surgery for a terminally ill friend. In her despair from the news, Arizona asked Callie to promise to never leave her. This reeks of foreshadowing.

April: She not only failed to pass her boards, but she also couldnt secure a position at any hospital, including Seattle Grace. Given her ultra-neurotic disposition, April has been quickly unraveling, culminating with a rapid exit from Joes bar last week as Avery tried to comfort her. To picture it is giving me chills, but I think we could see April commit suicide.

Take your guess below.

Read more: Greys Anatomy: Watch the first six minutes of the season finale VIDEO Greys Anatomy boss on the finale: I did what was necessary Greys Anatomy actors near deal to return

Read the original:
‘Grey’s Anatomy’ season finale: Who will die?

Who's Going to Die on the Grey's Anatomy Season Finale?

Grey's Anatomy

Who's going to die on the Grey's Anatomy eighth season finale?

Six doctors Meredith, Derek, Cristina, Mark, Lexie and Arizona crash-landed somewhere in the woods on their way to Boise. Though we'd like to think that April (Sarah Drew), who failed her boards, would kill herself and save us the torment of a more shocking loss the promos seem to indicate that it's one of the Stranded Six who won't make it out alive.

Grey's Anatomy Exclusive Finale Scoop: A Seattle Grace exodus and a "dark and twisty" event

So which character bites the dust? We weigh the pros and cons for each potential Seattle Grace casualty in order from most to least likely to die:

1.Lexie Grey (Chyler Leigh) Why She Will Die: We have come to love Little Grey, so when Shonda Rhimes told us the prospect of a reunion with Mark might be "bittersweet or painful," we were worried. Our guess? They finally reconcile just in time for one of them to die, which is why they're both at the top of this list. Why She Won't: Meredith has already stated that Lexie is one of the reasons she'd stay, so if the writers are planning to keep Mer at Seattle Grace, then why would baby sis have to die?

2. Mark Sloan (Eric Dane) Why He Will Die: Let's face it, Mark is only interesting when he's in a relationship with Lexie, and it's been an entire season since they were dating. And anyway, we're sick of the will-they-won't-they dynamic for a couple that was already together! Also: Rhimes' bittersweet comment above could also apply to Mark. Why He Won't: Slexie fans would be furious if the duo never did get back together. Plus: Do we really want to see Lexie have another mental breakdown like she did after the shooting?

Exclusive Grey's Anatomy Video: Which doctors will be leaving Seattle Grace?

3. Arizona Robbins (Jessica Capshaw) Why She Will Die: When Arizona cried to Callie (Sara Ramirez) about the impending loss of her friend Nick, she begged Callie to never leave, but moments later, Arizona was the one who took Alex's spot on the plane and flew off to Boise. When writers use the old foreshadowing technique like that, we get anxious. Also, how poetic would it be if the one person who wasn't supposed to be on the plane ended up dying? Writers love that! Why She Won't: Rhimes might fear the wrath of the LGBT community with whom she works closely with and is receiving a GLAAD award from should she kill off one of the few lesbian characters on network television.

4. Derek Shepherd (Patrick Dempsey) Why He Will Die: His death would singlehandedly reinvigorate the series because it would be a rebirth for Meredith. Sure, she would be sad and go through yet another long "dark and twisty" phase, but to see her come out the other side "bright and shiny" and single again would be a fun journey. (We'll be expecting your hate mail soon!) Why He Won't: He just finished the McMansion! In all seriousness, the likelihood of Derek being killed off is slim considering Dempsey, Ellen Pompeo, Sandra Oh, Justin Chambers, Chandra Wilson and James Pickens Jr. all reportedly signed two-year contracts last week, which Dempsey later confirmed at least for himself.

More:
Who's Going to Die on the Grey's Anatomy Season Finale?

Stem cell therapy to treat a chimp’s torn ACL may prove beneficial for humans

Veterinarians hope a new medical procedure can treat a 25-year-old chimpanzee with a torn ACL, or anterior cruciate ligament, at the "Save the Chimps" in Florida.

The procedure involves injecting the chimp with her own stem cells.

"With chimps we don't want to do a lot of surgical work, put hardware in their knee, they tend to pull out that sort of thing," said Veterinarian Linda Gregard, M.D.

Dr. Darrell Nazareth with the Florida Veterinary League has been using stem cells to treat dogs with arthritis for the past two years, but this is his first chimp.

"We're not using embryonic stem cells, we're not taking embryos and taking their stem cells from there. We're just using the patient's own tissue," said Dr. Nazareth.

The technology harnesses the bodies own ability to heal itself and doctors hope it could find wider use in humans.

After injecting two billion stem cells into Angie's knee, doctors will find out in the next two to three weeks if the stem cell therapy treatment was successful.

Go here to see the original:
Stem cell therapy to treat a chimp's torn ACL may prove beneficial for humans

Stem Cells for Spinal Cord Injury: Some Patients Have Long-Term Improvement

Thirty Percent of Patients Show Improved Functioning after Stem Cell Therapy

Philadelphia, Pa. (May 17, 2012) One of the first long-term studies of stem cell treatment for spinal cord injury shows significant functional and other improvements in three out of ten patients, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The results support the safety of mesenchymal stem cells (MSCs) derived from the patient's own bone marrow, showing "continuous and gradual motor improvement" in at least some patients with disability caused by spinal cord injury. The lead author of the new study was Dr. Sang Ryong Jeon of University of Ulsan College of Medicine, Seoul, South Korea.

Evidence of Improved Function after MSC Treatment for Spinal Cord Injury The researchers performed MSC transplantation in ten patients with permanent motor (movement) deficits or paralysis (paraplegia or quadriplegia) after spinal cord injury. Mesenchymal stem cells are a type of "multipotent" cell that can be cultured from adult bone marrow and induced to develop into many different types of cells.

The cultured MSCs were injected directly into the injured spinal cord and the surrounding (intradural) space. Additional cells were injected after another four and eight weeks. The results were assessed by measuring improvement in the patients' ability to move their arms and hands and to perform key activities of daily living. Imaging scans and tests of muscle activity were performed as well.

During the first six months after MSC transplantation, six of the ten patients showed improvement in motor power of the arms and hands. Of these, three patients had gradual improvement in the ability to perform daily activitiesfor example, preparing meals and typing on a keyboard.

These three patients also showed significant changes on MRI scans of the spinal cord, including evidence of healing around the injured area of the spine. They also had improvement in electrophysiologic studies of muscle electrical activity.

No Long-Term Safety Problems of MSC Transplant None of the ten patients had any permanent complications related to MSC transplantation. This helps to alleviate concerns that MSC injection could lead to later problems like the development of tumors or calcifications.

Previous studies have shown promising results with MSC transplantation in animals and humans with spinal cord injury. Mesenchymal cells have some important potential advantages for stem cell therapy, as they are a relatively easily accessible source of the patient's own cells. The ten patients treated by Dr. Jeon and colleagues represent the first attempt at direct spinal injection of MSCs for the treatment of spinal cord injury in humans.

Following up on a previous study reporting initial improvement in six patients, the new paper describes continued improvementincluding meaningful gains in the ability to perform everyday functional tasksin three patients. Dr. Jeon and colleagues note that all three patients with progressive improvement had some "residual neurological function." They write, "Therefore, MSC treatment is more likely to enhance the remaining neurological function rather than rengeneration." They call for further studies to understand the mechanism of improvement after MSC treatment and to clarify which patients with spinal cord injury are most likely to benefit.

See the rest here:
Stem Cells for Spinal Cord Injury: Some Patients Have Long-Term Improvement

Industry Consultant Gregory Bonfiglio Joins California Stem Cell Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--

California Stem Cell, Inc. (CSC) announced today that well-known stem cell & regenerative medicine industry veteran Gregory A. Bonfiglio, J.D. has joined its Board of Directors.

Gregory Bonfiglio has over 25 years of experience working with technology companies, and was an early investor in the stem cell industry. He is Managing Partner of Proteus Venture Partners, an investment & advisory firm he founded in early 2006 to provide venture funding and strategic advisory services in the stem cell & regenerative medicine space. Mr. Bonfiglio is on the Boards of VistaGen Therapeutics and StemCyte, Inc.; he is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine (RM Translation Center in Toronto, Canada). In addition, Mr. Bonfiglio sits on the Advisory Board and Finance Committee of the International Society for Stem Cell Research (ISSCR); he is on the Commercialization Committee of the International Society for Cellular Therapy (ISCT).

Mr. Bonfiglio brings to CSC an extensive background in strategic consulting, having held partnership positions with various legal and venture firms, and having successfully led a team that took pioneering stem cell company Advanced Cell Technology public in early 2005. Were thrilled to welcome to our board someone with the breadth of industry experience that Greg has, and are very much looking forward to his participation in the continued growth of this Company, said COO Chris Airriess.

This appointment coincides with a ramp up of commercial product sales as well as advancements of CSCs active Phase II clinical trial in metastatic melanoma.

About California Stem Cell

California Stem Cell Inc. (CSC) is an Irvine, CA based company which has developed proprietary methods to generate human stem cell lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes. CSC is able to supply its human cell populations to companies and institutions worldwide for use in the development of therapies, efficacy screening or the creation of toxicity profiles for candidate drugs, and experimental research tools.

CSC is focused on the development of stem cell based therapies for spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS, or Lou Gehrigs Disease), and metastatic cancers.

Follow us on Twitter: http://twitter.com/castemcell

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50281529&lang=en

Excerpt from:
Industry Consultant Gregory Bonfiglio Joins California Stem Cell Board of Directors

Osiris Wins Canadian Approval for First Stem-Cell Therapy

By Meg Tirrell - 2012-05-17T20:35:40Z

Osiris Therapeutics Inc. (OSIR) said it won the worlds first approval for a stem-cell drug, gaining clearance in Canada to sell Prochymal for a disease that can attack patients who received bone-marrow transplants.

Prochymal was approved for the treatment of acute graft versus host disease in children for whom steroids havent worked, the Columbia, Maryland-based company said today in a statement. Steroids have a 30 percent to 50 percent success rate, and severe GvHD can be fatal in 80 percent of cases, according to the company.

The therapy uses mesenchymal stem cells derived from bone marrow that can take on different forms, to combat the immune reaction that causes patients to literally peel out of their skin and shed their intestinal lining, Osiris Chief Executive Officer Randal Mills said in a telephone interview. The disease has no equal.

The company hasnt sought approval for this indication in the U.S., where regulators asked for more data before considering whether to allow sales of the drug, Mills said. Prochymal already is used in eight countries, including the U.S., on an expanded-access program basis, which allows patients to receive experimental medicines without participating in clinical trials.

This is the first regulatory approval of a stem-cell drug -- where the active ingredient of the drug is a stem cell -- in the world, Mills said. Its a huge deal for us and a huge deal for the entire field of stem-cell therapy.

Osiris fell less than 1 percent to $5.26 at the close of trading in New York. The shares have declined from an all-time high of $28.56 in 2007 as Osiris faced clinical setbacks, including two studies in 2009 that failed to show statistical improvement of Prochymal versus placebo.

The Canadian approval was based on data showing a clinically meaningful response 28 days after starting therapy for 61 percent to 64 percent of patients treated, Osiris said in the statement.

Prochymal may draw $16.7 million in revenue next year with Canadian approval, estimated Edward Tenthoff, an analyst with Piper Jaffray & Co. He said that while Prochymal, if successful in Canada, would be the first stem-cell drug to receive approval, other regenerative products used for wound-healing that employ stem cells are already on the market, such as Carticel from Sanofis Genzyme unit. That treatment uses a patients own cells to repair cartilage injuries in the knee, and is implanted with surgery, whereas Prochymal is an intravenous, off-the-shelf therapy. The stem cells are derived from bone marrow donations from healthy donors.

Progress in stem-cell research has been halting. Geron Corp. (GERN), based in Menlo Park, California, started the first U.S.- approved trial of human embryonic stem cells before ending the program last year because of research costs and regulatory complexities.

Go here to read the rest:
Osiris Wins Canadian Approval for First Stem-Cell Therapy

World’s First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal

COLUMBIA, Md.--(BUSINESS WIRE)--

Osiris Therapeutics Inc. (NASDAQ:OSIR - News) announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children. The historic decision marks the worlds first regulatory approval of a manufactured stem cell product and the first therapy approved for GvHD a devastating complication of bone marrow transplantation that kills up to 80 percent of children affected, many within just weeks of diagnosis.

"I am very proud of the leadership role Canada has taken in advancing stem cell therapy and particularly gratified that this historic decision benefits children who would otherwise have little hope," said Andrew Daly, M.D., Clinical Associate Professor, Department of Medicine and Oncology at the University of Calgary, Canada and Principal Investigator in the phase 3 clinical program for Prochymal. "As a result of Health Canada's comprehensive review, physicians now have an off-the-shelf stem cell therapy in their arsenal to fight GvHD. Much like the introduction of antibiotics in the late 1920's, with stem cells we have now officially taken the first step into this new paradigm of medicine."

Prochymal was authorized under Health Canada's Notice of Compliance with conditions (NOC/c) pathway, which provides access to therapeutic products that address unmet medical conditions and which have demonstrated a favorable risk/benefit profile in clinical trials. Under the NOC/c pathway, the sponsor must agree to carry out confirmatory clinical testing.

Today is not only a great day for Osiris, but for everyone involved in the responsible development of stem cell therapies, said C. Randal Mills, Ph.D., President and Chief Executive Officer of Osiris. Most importantly, today is a great day for children and their families who bravely face this horrific disease. While today marks the first approval of a stem cell drug, now that the door has been opened, it will surely not be the last.

Health Canadas authorization was made following the recommendation of an independent expert advisory panel, commissioned to evaluate Prochymal's safety and efficacy. In Canada, Prochymal is now authorized for the management of acute GvHD in children who fail to respond to steroids. The approval was based on the results from clinical studies evaluating Prochymal in patients with severe refractory acute GvHD. Prochymal demonstrated a clinically meaningful response at 28 days post initiation of therapy in 61-64 percent of patients treated. Furthermore, treatment with Prochymal resulted in a statistically significant improvement in survival when compared to a historical control population of pediatric patients with refractory GvHD (p=0.028). The survival benefit was most pronounced in patients with the most severe forms of GvHD. As a condition of approval, the clinical benefit of Prochymal will be further evaluated in a case matched confirmatory trial and all patients receiving Prochymal will be encouraged to participate in a registry that will monitor the long-term effects of the therapy.

Refractory GvHD is not just deadly to the patients it afflicts, but is devastating for the family, friends, and caregivers who watch helplessly as the disease progresses, said Joanne Kurtzberg, MD, Head of the Pediatric Bone Marrow Transplant Program at Duke University and Lead Investigator for Prochymal. "I have personally seen Prochymal reverse the debilitating effects of severe GvHD in many of my patients and now, after nearly two decades of research, the data demonstrating consistently high response rates, a strong safety profile and improved survival clearly support the use of Prochymal in the management of refractory GvHD."

Prochymal is currently available in several countries, including the United States, under an Expanded Access Program (EAP). Prochymal will be commercially available in Canada later this year.

Today Osiris turns the promise of stem cell research into reality, delivering on decades of medical and scientific research, said Peter Friedli, Chairman and Co-founder of Osiris. It took 20 years of hard work and perseverance and I want to personally thank everyone involved for their dedication to this important mission.

In addition to the extensive intellectual property protection Osiris has around Prochymal, which includes 48 issued patents, Health Canada's decision will also provide Prochymal with regulatory exclusivity within the territory. Canada affords eight years of exclusivity to Innovative Drugs such as Prochymal, and an additional six-month extension is available since it addresses a pediatric population.

Read more:
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal

Can Too Much Sugar Make You Stupid?

May 16, 2012

Dentists have long warned that too much sugar can rot a persons teeth, but scientists at UCLA have discovered evidence that too much soda and candy could also rot a persons brain.

The study, which was published Tuesday in the Journal of Physiology, discovered how a diet that is steadily high in fructose can slow down the function of the brain, impairing memory and learning ability, the Los Angeles-based university said in a May 15 press release. Those adverse effects, they say, can emerge in as little as six weeks time, but can be counteracted to some degree by adding omega-3 fatty acids to ones diet.

Our findings illustrate that what you eat affects how you think, Fernando Gomez-Pinilla, one of the authors of the study and a professor of neurosurgery at the David Geffen School of Medicine at UCLA said in a statement. Eating a high-fructose diet over the long term alters your brains ability to learn and remember information. But adding omega-3 fatty acids to your meals can help minimize the damage.

Were not talking about naturally occurring fructose in fruits, which also contain important antioxidants, Gomez-Pinilla, a professor of integrative biology and physiology in the UCLA College of Letters and Science as well as a member of UCLAs Brain Research Institute and Brain Injury Research Center, added. Were concerned about high-fructose corn syrup that is added to manufactured food products as a sweetener and preservative.

Gomez-Pinilla and co-author Rahul Agrawal, a visiting postdoctoral fellow, studied two groups of rats that were given a solution that contained high-fructose corn syrup as drinking water for a six-week period, according to AFP reports. One of the groups was also given flaxseed oil and docosahexaenoic acid (DHA), both omega-3 fatty acids, while the other was not.

Prior to the start of the experiment, both groups of rats completed a five-day training session on how to navigate a complex maze. Following six weeks of the corn syrup treatment, they were re-entered into the maze, and the researchers observed their performance. Gomez-Pinilla told AFP that the rodents that did not receive DHA and flaxseed oil were slower and demonstrated a decline in synaptic activity.

They also showed signs of insulin-resistance, according to the UCLA press release.

Because insulin can penetrate the bloodbrain barrier, the hormone may signal neurons to trigger reactions that disrupt learning and cause memory loss, Gomez-Pinilla said. Insulin is important in the body for controlling blood sugar, but it may play a different role in the brain, where insulin appears to disturb memory and learning. Our study shows that a high-fructose diet harms the brain as well as the body. This is something new.

Our findings suggest that consuming DHA regularly protects the brain against fructoses harmful effects, he added. Its like saving money in the bank. You want to build a reserve for your brain to tap when it requires extra fuel to fight off future diseases.

See more here:
Can Too Much Sugar Make You Stupid?

Chain restaurants don't meet U.S. nutrition guidelines, study says

Plenty of restaurants have been advertising their efforts to offer healthful choices, and its possible to eat carefully just about anywhere. But researchers say nearly all the entrees they reviewed at 245 U.S. chains fail to meet federal guidelines.

Think about it, and you can figure out some likely culprits: burgers with cheese, bacon and sauce; pastas with four cheeses and sausages; outsize servings of meat; salads covered in fatty, salty dressings.

For a study published online in the journal Public Health Nutrition, researchers looked at the nutritional content of 30,923 menu items, including those from childrens menus, from 245 brands of restaurants. They found that 96% of them failed to meet recommendations for the combination of calories, sodium, fat and saturated fat set by theU.S. Department of Agriculture.

The restaurants included fast-food, buffet, takeout, family style and upscale restaurants, said Helen Wu, one of the authors and an assistant policy analyst at the Rand Corp. in Santa Monica. The study was supported by the Robert Wood Johnson Foundation.

The majority of the entrees did not exceed 667 calories one-third of the calories the USDA estimates the average adult needs each day, said Wu and Roland Sturm, senior economist at Rand. They looked at restaurants websites from February to May 2010.

But they found that few of the entrees met recommended limits when considering calories, sodium, saturated fat, and fat combined.

Many items may appear healthy based on calories, but actually can be very unhealthy when you consider other important nutrition criteria, Wu said.

The sodium count often put a restaurant over the limit. (The USDAs daily recommended limit for most adults is 2,300 milligrams.)

The entrees in family style restaurants -- places such as Pizza Hut, Red Lobster and Dennys -- had higher levels of the items studied than fast-food restaurants: 271 more calories on average, and 16 grams more fat and 435 mg more sodium, Wu said.

Serving size counts, too.

View original post here:
Chain restaurants don't meet U.S. nutrition guidelines, study says

RCPS nutrition director gets state award

Malcolm Quillen, president of the Georgia School Nutrition Association, recently presented Peggy Lawrence, director of School Food Services for Rockdale County Public Schools, with the award for GSNA's Director of the Year at its annual conference in Athens.

CONYERS -- One of Rockdale County Public Schools' program directors recently won a state award for her leadership.

The Georgia School Nutrition Association named Peggy Lawrence, director of School Food Services for RCPS, as its Director of the Year at the annual conference in Athens.

"I was completely surprised when the award was announced. I am tremendously honored," Lawrence said. "I feel very fortunate to have a job that I love to do, day after day, year after year. I get up every day excited to come to work. I work with great people in an even better school district."

Lawrence is in her 14th year at RCPS and in her 12th year as director of school nutrition. She worked in Gwinnett County Schools as a cafeteria manager for about two years before coming to RCPS in 1999.

"She is very dedicated to and very passionate about school food nutrition and the impact it has on our students' learning," Phil Budensiek, chief operations officer at RCPS. "Her responsibilities are not a 'job she has to go to' but a calling that she fulfills every day with energy, competence and passion. She is a service focused person with a tremendous love for and dedication to our students, her staff and school nutrition. She is well deserving of this recognition, and I'm so very proud of her and her accomplishments."

GSNA officials said the Director of the Year is accomplished in program enhancement, staff development, school involvement, association involvement and community involvement.

They praised Lawrence for constant monitoring and extensive manager training to bring the Rockdale County program out of poor financial shape when she came on board.

The program, which is a self-supporting fund, has been able to renovate three kitchens because of financial results over the last few years, and three Rockdale County public schools are among 146 schools across the state that were awarded a grant from the United States Department of Agriculture's Fresh Fruit and Vegetable Program for this school year.

The association also applauded her for starting the tradition of RCPS celebrating National School Lunch Week, which allows for school and community leaders to serve alongside other nutrition staff. They also enjoy the fact that 38 percent of her staff members are ServSafe certified.

Read the original:
RCPS nutrition director gets state award

International Fitness and Nutrition Expert Michael Torchia Teams up with Learning Research, Inc.

AUSTIN, Texas--(BUSINESS WIRE)--

eDoorways International Corporation (Pink Sheets: EDWY) announced today that its wholly owned subsidiary, Learning Research Inc, has teamed up with renowned fitness expert Michael Torchia of Operation Fitness. In unveiling our first set of products to the world, were thrilled to team up with Michael Torchia to provide a new tool for teaching correct methods of exercise and proper nutrition, stated Bob Wesson, CEO of Learning Research Inc. Michael is unquestionably the most diverse and qualified fitness expert in the world today.

Michael Torchia has created a multi-disciplined lifestyle conglomerate, the first in its category that focuses on every phase of the lifestyle process, including physical fitness and nutritional solutions. He offers a fresh, effective approach to fitness that helps the entire family create and maintain a healthy lifestyle. Torchias innovative programs are interactive and help both children and adults achieve optimal fitness levels through age-appropriate exercise and nutritious eating. Michael - whose expertise has made him a public person as well, brings to his clients a personalized program that combines diet, physical training, and mental acuity. Michael has worked extensively with members of the Royal Families of Saudi Arabia, Brunei, Qatar and is affectionately termed by them as the "Beverly Hills Healer."

Unlike many famous trainers who tout their celebrity clientele, Michael steps up and changes lives on a grander scale, continued Wesson. Michael has created new ways of life for tens of thousands of individuals around the world and is the fitness advisor to such luminaries as Kevin Spacey, Al Pacino and Matt Damon, to name a few.

For over 2 decades, my clients have said over and over how they wish I could be cloned, stated Michael Torchia, founder of Operation Fitness. Now through our partnership with LRI, we can make this happen. Im looking forward to taking my diverse expertise in health and fitness and making it available to everyone.

According to sources close to the Company, Michael is dedicated in helping as many people as possible, and has a special place in his heart to cure the child obesity epidemic. I was an obese child growing up, continued Torchia. The doctor called me and my mother into his office and told me that if I didnt lose weight, I would be stricken with health problems such as diabetes and heart disease when I was older; I quickly changed my lifestyle. Michael works with some of the most influential child health advocates in the world including the current U.S. Surgeon General and First Lady Michelle Obama to promote proper nutrition and daily exercise among children across the nation.

What makes Michael different from the celebrity trainer is that Michael not only develops health and fitness programs for his clientele, he develops new ways of life, stated Chris Mitchell, CFO of Learning Research, Inc. Michael genuinely wants to make a difference in the lives of everyday people as expressed by his campaign to Shape Up America and globally recognizable Operation Fitness. Were thrilled about our new relationship with a man who wears so many hats so successfully, yet continues to promote a healthy lifestyle to anyone in the world who seeks it.

The mission of Operation Fitness is to educate, motivate and inspire people to lead healthier lives by using technology and multiple distribution platforms and venues. After interacting with the Learning Research board of directors for the past few weeks, we concluded that this would be the perfect platform to offer individualized health and fitness programs, to bring about a positive change in the lives of people around the world, continued Torchia. Using LRIs powerful artificial intelligence technology, we plan to reach people on a much greater scale and improve the populations health, one person at a time.

For more information on eDoorways International Corporation and/or the "eDoorways 2.0 platform," please visit our website at http://www.eDoorways.com or e-mail a package request to Jeffrey@HeritageCorporateServices.com. You can also make comments via Twitter (http://twitter.com/edoorways).

Safe Harbor for Forward-Looking Statements:

More here:
International Fitness and Nutrition Expert Michael Torchia Teams up with Learning Research, Inc.

Six National Nutrition Awards to Be Presented May 18

Newswise May 17, 2012, St. Petersburg, Fla.Six national awards recognizing special achievement in sports nutrition will be presented on the evening of May 18 by the Collegiate & Professional Sports Dietitians Association (CPSDA) to three sports registered dietitians (Sports RDs), two college students, and the Director of Athletics from the University of Missouri during the awards banquet at the 4th Annual CPSDA Conference and Symposium in St. Pete Beach, Fla.

CPSDA was formed three years ago to unify Registered Dietitians who specialize working day-to-day with athletes competing at the highest levels of major college and professional sports, the Olympics, U.S. military and in law enforcement. Special recognition is awarded once per year by CPSDA for advancing the practical application of sports nutrition, and for raising awareness of the measurable benefits that Sports RDs contribute to the health and performance of athletes and others engaged in high-intensity activities.

Three of the six awardsfor Service, Perseverance and Trailblazerwere presented for the first time last year. The other three are being awarded for the first time in 2012, including the Tom Osborne Award, presented in the name of the University of Nebraskas Athletic Director and former three-time national championship coach who has been instrumental since 1982 in leveraging nutrition as an instrument of athletic performance to complement sports medicine and strength and conditioning.

Recipients of the 2012 CPSDA national awards are:

2012 CPSDA Service AwardAllison Maurer, MS, RD, CSSD, CSCS

Allison Maurer, MS, RD, CSSD, CSCS, Sports Dietitian since 2007 for the University of Tennessee, in recognition of invaluable contributions and outstanding service given to her profession and CPSDA. Maurer, who was elected to the 9-member CPSDA Board of Directors in March, is most widely noted among her peers for irrepressible enthusiasm in promoting the work of Sports RDs. She responsible for performance nutrition for the UT men's and women's athletic departments. Her duties include analyzing athletes' nutritional status, working with Team ENHANCE, creating meal plans and providing nutrition education on the team and one-on-one basis. Allison earned her bachelors of science degree in dietetics from Olivet Nazarene University in Bourbonnais, IL and her masters in nutrition from Georgia State University in Atlanta. She spent three years at the University of Colorado (2004-2007) as nutritionist and assistant strength coach before arriving in Knoxville.

2012 CPSDA Perseverance AwardJoel Totoro, RD

Joel Totoro, RD, who left the New England Patriots this month to become full-time Sports RD for the University of Michigan, receives this award in recognition of immeasurable enthusiasm and extraordinary dedication given to his profession and the CPSDA. Totoro served eight years as both nutrition consultant and Sports RD for the NFLs New England Patriots, who returned again to the Super Bowl in 2012. Ironically, he extolled the advantages of being a Sports RD for far fewer athletes while working in professional sports in the CPSDA documentary Sports RDs Rising shortly before accepting his new position, which will require him to work directly with approximately 600 athletes at UM. He graduated in 2002 from the University of Connecticut with a bachelors degree in Allied Health/Dietetics before serving in a nutrition consulting capacity for Sodexho (food service), Eastern Connecticut Health Service, and South Coast Hospital Group in New England between 2002 and 2004.

2012 CPSDA Trailblazer AwardMichelle Rockwell, MS, RD, CSSD

Pioneers in sports nutrition are revered by their colleagues because the road to recognition and respect in the highly competitive athletic community has spanned three challenging decades, nearly all of that time working long hours in near anonymity. Veteran Sports RD Michelle Rockwell, MS, RD, CSSD, is a sports nutrition consultant who operates her own company Michelle Rockwell Consulting out of Raleigh-Durham, NC. She becomes the second recipient of the CPSDA Trailblazer Award in recognition of the visionary goals and groundbreaking innovation brought to her profession and the CPSDA. Rockwell was among the first five full-time Sports RDs in the U.S., having developed the first sports nutrition program at the University of Florida. Today she serves as nutrition consultant to athletic departments and professional

View post:
Six National Nutrition Awards to Be Presented May 18

Top UK Sports Nutrition Company unveils new Vegan Protein

LONDON, May 17, 2012 /PRNewswire/ --Available throughout Europe from the beginning of June, new Vegan Protein is one of only a handful of protein powders that is specifically formulated for Vegans. It has to be one of the greenest protein powders in the world, not only is it derived from an environmentally sound crop of peas but it's also made using 100% Green Energy.

The vegan sourced protein in Vegan Protein is made from a patented manufacturing process. The unique and environmentally friendly process extracts pure European pea protein using water and no chemicals. This has led to what Reflex Nutrition believe to be the perfect instant mixing vegan protein powder that's highly digestible and directly comparable to the best animal sources of protein like whey, eggs and milk. The great tasting instant mixing protein powder provides 75% protein that has 98% digestibility and a great amino acid score of 95%.

The research and development team at Reflex Nutrition are also keen to point out that the critically important Branch Chain Amino acids, L-Leucine, L-Isoleucine and L-Valine, which are responsible for building, repairing and maintaining muscle tissue are in abundance; in fact pea protein contains more BCAAs than the best egg white protein. Further Pea Protein contains up to double the amount of Arginine, responsible for growth, repair and Nitric Oxide synthesis, when compared to whey protein.

Managing Director James Phillips comments,

"We've wanted to manufacture a truly first class vegan protein powder for a number of years and it's taken plenty of research & development to bring us to the point when we felt we were happy with finished product. We thoroughly researched a number of vegan based proteins but only one was deemed suitable. The protein needed to hypoallergenic, environmentally sound and provide an exceptional nutritional profile. In conjunction with this we were waiting for a natural sweetener to use in the product, Stevia was the obvious choice which became legal for use in food product late last year. I'm very impressed with Reflex Vegan Protein, it ticks all boxes for Vegans and it represents excellent value for money."

Vegan Protein will be available from the beginning of June with a RRP of 44.95 pounds Sterlingfor a 2.1kg tub.

Reflex Nutrition is the U.K's No.1 sports nutrition manufacturer, operating from their new state of the art facilities at The Science Park on the outskirts of Brighton.

Media Contact:

James Phillips james.phillips@reflex-nutrition.com +44 1273 303817

View post:
Top UK Sports Nutrition Company unveils new Vegan Protein

Wiley-Blackwell launches new open-access journal: Food Science & Nutrition

Public release date: 17-May-2012 [ | E-mail | Share ]

Contact: Ben Norman Lifesciencenews@wiley.com 44-124-377-0375 Wiley-Blackwell

Hoboken, NJ May 17th 2012. Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., today announced the launch of Food Science & Nutrition as part of the Wiley Open Access publishing program. The journal will provide authors with a new platform for the rapid dissemination of the latest research and will be published in collaboration with the Society of Chemical Industry, the Institute of Food Science & Technology and other prominent societies.

Food Science & Nutrition will publish the latest peer reviewed research from across all areas of food sciences, but will focus on the results of fundamental and applied research related to human food and nutrition. The journal will also publish reviews, research methods, invited editorial pieces and commentaries.

Food Science & Nutrition will be edited by Dr. Y. Martin Lo, Associate Professor of Food Bioprocess Engineering at the University of Maryland. Dr. Lo is also the Editor-in-Chief of the Journal of Food Processing and Preservation, a position he has held since 2007. An expert team of editorial board members will work alongside Dr. Lo, including Associate Editor, Dr. Berna Magnuson of the University of Toronto.

Food Science & Nutrition is the latest addition to Wiley's portfolio of food science journals and will benefit from relationships with titles including Molecular Nutrition & Food Research which has an Impact factor of 4.3 and holds the top ISI rank for Food Science and Technology.

Dr. Lo commented that, "The science of food has evolved significantly over the last two decades and it has become clear that integrated research to interpret the interface between food science and nutrition is critical in attaining full comprehension of functional foods. Additionally, many countries are still in dire need of appropriate technologies to add value to their abundant agriculture products/byproducts, while developed countries are seeking better practices to sustain agriculture. All these efforts take time and need a proper outlet to usher continuous development and stimulate effective communications. It is my vision for Food Science & Nutrition to be the one-stop hub for such."

"Food Science & Nutrition will provide researchers and authors with a rapid, yet rigorous, peer review process combined with high visibility for their research papers," says Rachel Burley, VP and Publisher, Life Sciences, Wiley-Blackwell. "The journal will be an important channel for research that will benefit multiple disciplines".

###

Please visit the Food Science & Nutrition website for further information and future updates:

Read the original:
Wiley-Blackwell launches new open-access journal: Food Science & Nutrition

Student-to-Student Nutrition Education Made Possible Thanks to New Partnership Between Sodexo and 12-Year-Old Tulsa …

GAITHERSBURG, Md., May 16, 2012 /PRNewswire/ --Students in school districts nationwide are learning about good nutrition from their parents, teachers and school nutrition team members, but there isn't a lot of peer-to-peer dialog on this vitally important issue. An innovative new partnership between Sodexo and Chef Remmi Smith, an 12-year-old aspiring chef in Tulsa, Okla., is bringing a new kid-level perspective to nutrition education and allowing students to learn from one of their own.

(Photo:http://photos.prnewswire.com/prnh/20120516/NE08726 )

Sodexo just named Remmi the company's first-ever Student Ambassador to Health and Nutrition and in that role she will have an opportunity to positively impact the lives of students in nearly 500 Sodexo-served school districts across the country.

Already a champion of studentnutrition and wellness through social media/digital media channels and her "Cook Time with Remmi" online and TV show, Chef Remmi will now have an opportunity to reach more students across the country than ever before by working closely with Sodexo to help students get excited about good nutrition. With this partnership, Remmi will also be able to take a student nutrition leadership role by inspiring kids to make healthy food choices both in and out of school.

"I'm so excited to be a role model and to have a chance to help kids live healthier lives," said Chef Remmi. "It makes me feel really good knowing that students all over the country will benefit from my love of both nutrition and cooking!"

Although she just started in her new ambassador role, Chef Remmi already made splashes at two national events. Remmi stole the show when she appeared with Sodexo representatives at both the National School Boards Association 2012 Annual Conference & Exposition in Boston in April and the National Restaurant Association's NRA Show 2012 in Chicago in early May.

"As our Student Ambassador to Health and Nutrition, Chef Remmi cangive us the viewpoint ofour ultimate customer the children we serve every day. She can also provide invaluable insight into ways we can enhance our programs to better meet students' needs," said Steve Dunmore, president of Sodexo Education-Schools. "I am excited about this partnership and I can't wait to see all the great things Chef Remmi and Sodexo can do together."

Chef Remmi

Chef Remmi has distinguished herself through her work in digital, social and mainstream media and she is recognized as a nutrition and wellness expert that can truly relate to students and the challenges they face daily. For more information regarding Chef Remmi, please visit http://www.cooktimewithremmi.com/.

Sodexo in North America

Originally posted here:
Student-to-Student Nutrition Education Made Possible Thanks to New Partnership Between Sodexo and 12-Year-Old Tulsa ...

Creative Edge Nutrition, Inc. Announces New Executive Appointment

ORLANDO, FL--(Marketwire -05/17/12)- Creative Edge Nutrition, Inc. (FITX.PK), a nutritional supplement company focusing on active lifestyles, announced today that Jeff Thomas has been appointed to Vice President of Distributor Relation and Brand Management for Creative Edge Nutrition, Inc.

Mr. Jeff Thomas, founder of Science Defined Nutrition, Inc. ("SDN"), which was recently acquired by Creative Edge Nutrition, Inc., has held various industry jobs including Vice President Sales for Supplement Group, Inc. and over 10 years Global experience in setting up international and distributor contracts in the sport nutrition industry. He was also a national sales representative for Dox, LLC which was the parent company for Legal Gear also known as LG Sciences. As a point of clarification, Jeff Thomas is of no relation to Paul Thomas, one of Creative Edge Nutrition, Inc.'s original founders.

Bill Chaaban, President and CEO of Creative Edge Nutrition, Inc., stated, "Jeff Thomas adds distribution expertise that will accelerate the company's growth. We will continue to aggressively grow and expand our presence in the sports nutrition marketplace through both organic growth and strategic acquisitions."

About Science Defined Nutrition, Inc.Developed by body builders and athletes, Science Defined Nutrition (SDN) is a leader in nutritional supplement industry. SDN's Research and Development Team has cultivated an entire litany of superlative products, with the initial proof-providing ground-breaking product ROGUE at the helm, rooted in the immeasurable passion for achieving athletic enhancement through tireless scientific scrutiny. The core Mission of SDN is to assist our customers in taking their athletic ambitions to heights unknown, without having to defy their own conscience by sacrificing their state of health to do so. http://www.sciencedefinednutrition.com and http://www.facebook.com/Sciencedefinednutrition

About Creative Edge Nutrition, Inc.Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.CenergyNutrition.com and http://www.facebook.com/pages/Creative-Edge-Nutrition-Inc/115224738609211

Safe Harbor Notice This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Go here to see the original:
Creative Edge Nutrition, Inc. Announces New Executive Appointment

Science reporters win ASM Public Communications Award

Public release date: 16-May-2012 [ | E-mail | Share ]

Contact: Garth Hogan ghogan@asmusa.org American Society for Microbiology

Washington, DC May 14, 2012 The 2012 winners of the ASM Public Communications Award are Jon Cohen and Martin Enserink from Science. "False Positive" was published in Science on September 23, 2011. The article digs deep into the controversy surrounding the publication of a study that linked a mouse retrovirus, XMRV, to chronic fatigue syndrome (CFS).

Cohen and Enserink spoke with scientists and CFS patients around the world for four months, attended meetings in the US and Europe to report on all sides of the controversy. Their work resulted in an 8-page story in which Cohen and Enserink carefully chronicled how the XMRV hypothesis arose, how it was embraced by patients and media, and eventually disproved by research.

The Award recognizes outstanding journalistic achievement in increasing public awareness, knowledge, and understanding of microbiology. The Public Communications Award, which includes a $2500 honorarium, will be presented during a ceremony at the ASM General Meeting, June 16-19 in San Francisco, CA.

'False Positive' contributed to the public understanding of microbiology by documenting, in meticulous detail, just how the field operates when confronted with a result that doesn't hold up.

Judges for the award were Debora MacKenzie of New Scientist; Maryn McKenna of Wired; and Terry Murray of The Medical Post. Judges described 'False Positive' as "extremely thorough and thoughtful" and a "thorough review of the XMRV/CFS hypothesis and attendant controversy".

Martin Enserink has been a reporter and editor for Science magazine since 1999, first at the magazine's Washington D.C. headquarters and later in Paris. He now is a contributing news editor based in Amsterdam, the Netherlands. He specializes in infectious diseases and global health.

A correspondent with Science since 1990, Cohen also has written for the New Yorker, Atlantic Monthly, the New York Times Magazine, Smithsonian, Outside, Slate, Technology Review, and many other publications. His books include Shots in the Dark, Coming to Term and Almost Chimpanzee.

###

Read the original:
Science reporters win ASM Public Communications Award